BiochemAPIRetatrutide
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including BiochemAPI rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 4 Aug 2026 | Fail | rmre5td Tested | lab name | View COA | |||
| 3 Mar 2026 | Fail | 8ur9njd Tested | lab name | View COA | |||
| 4 Feb 2026 | Pass | m4pw52g Tested | lab name | View COA | |||
| 26 Jan 2026 | Pass | k6sj6v9 Tested | lab name | View COA | |||
About BiochemAPI test results from Finnrick
BiochemAPI is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 4 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible BiochemAPI peptides in this dataset are Retatrutide (4 tests) and Tirzepatide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 4 recent tests.